Cantor and Oppenheimer & Co. are acting as lead book runners.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BIVI:
- BioVie to Present Data on Characterizing Hospitalization Burden of Ascites at AASLD Liver Meeting 2022
- BioVie reports full enrollment in Phase 2 trial of NE3107
- BioVie’s Phase 2 Trial Assessing NE3107’s Pro-motoric Activity in Parkinson’s Disease is Fully Enrolled
- BioVie provides pipeline update in letter to shareholders
- BioVie to Participate in Cantor Fitzgerald’s Neurology & Psychiatry Conference